With the discovery of new biomarkers for the early detection of acute myocardial infarction
(AMI), advancements in valid medication, and percutaneous coronary intervention (PCI), the …

Electrocardiography and high-sensitivity cardiac troponin testing are routinely applied as the
initial step for clinical evaluation of patients with suspected non-ST-segment elevation …

(1) Background: While an artificial intelligence (AI)-based, cardiologist-level, deep-learning
model for detecting acute myocardial infarction (AMI), based on a 12-lead electrocardiogram …

Aims To develop an artificial intelligence-based approach with multi-labelling capability to
identify both ST-elevation myocardial infarction (STEMI) and 12 heart rhythms based on 12 …

Abstract The Acetyl Salicylic Elimination Trial (ASET) Japan pilot study is a multicentre,
single-arm, open-label, proof-of-concept study with a stopping rule based on the occurrence …

The recommended maintenance dose of prasugrel for East Asian populations (ie, Japanese
and Taiwanese) is 3.75 mg as part of dual antiplatelet therapy (DAPT) for the prevention of …

Secondary prevention of acute MI, both ST elevated and non-ST elevated is essential to
reduce cardiovascular mortality and hospital readmission, ensuring patients return to …

Objective Controlling of low-density lipoprotein cholesterol (LDL-C) in patients with acute
coronary syndrome (ACS) remains a challenge. Health information technology (HIT) is …

Background Successful implementation of practice guidelines has been challenging in the
treatment of acute coronary syndrome (ACS), leaving room for improvement. A nationwide …

Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor for 6-12 months is the
current standard treatment for patients after percutaneous coronary intervention (PCI) …